Rang	Name	Position
1	Mr. Christopher M. Hall	CEO & Director
2	Dr. Richard Chen M.D., M.S.	President & Chief Medical Officer
3	Mr. Aaron L. Tachibana	CFO & COO
4	Dr. Russ B. Altman M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
5	Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
6	Dr. Michael P. Snyder Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
7	Mr. Ashish Kheterpal	Senior VP & Chief Information Officer
8	Mr. Stephen M. Moore J.D.	Senior VP, Chief Legal Officer & Corporate Secretary
9	Dr. Christian Haudenschild Ph.D.	Senior Vice President of Genomic Science
10	Mr. Stephane Mouradian Ph.D.	Senior Vice President of Business Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Merck & Co Inc	13,15%	0,23 Mrd. USD
2	ARK Investment Management LLC	7,74%	0,13 Mrd. USD
3	BlackRock Inc	6,63%	0,11 Mrd. USD
4	Lightspeed Management Co LLC	5,71%	0,10 Mrd. USD
5	Ameriprise Financial Inc	5,70%	0,10 Mrd. USD
6	Deep Track Capital, LP	3,75%	0,06 Mrd. USD
7	Aberdeen Group PLC	3,51%	0,06 Mrd. USD
8	Vanguard Capital Management, LLC	2,82%	0,05 Mrd. USD
9	Casdin Capital, LLC	2,39%	0,04 Mrd. USD
10	Kennedy Capital Management Inc	2,21%	0,04 Mrd. USD
11	Geode Capital Management, LLC	1,71%	0,03 Mrd. USD
12	Bank of America Corp	1,70%	0,03 Mrd. USD
13	AIGH Capital Management, LLC	1,61%	0,03 Mrd. USD
14	Blue Water Life Science Advisors, LLC	1,57%	0,03 Mrd. USD
15	Dimensional Fund Advisors, Inc.	1,40%	0,02 Mrd. USD
16	State Street Corp	1,39%	0,02 Mrd. USD
17	Morgan Stanley - Brokerage Accounts	1,19%	0,02 Mrd. USD
18	The Goldman Sachs Group Inc	0,87%	0,02 Mrd. USD
19	HRT FINANCIAL LLC	0,87%	0,02 Mrd. USD
20	Nuveen, LLC	0,71%	0,01 Mrd. USD